Integra tumbles after FY profit forecast trimmed

Shares of medical equipment maker Integra Lifesciences IART.O down 27.3% at $12.25, after hitting more than 13-year low of $11.60

Co cuts annual adj. EPS to between $2.19 and $2.29 from previously prior view of $2.41 to $2.51

IART estimates tariffs to hit FY earnings by 22 cents/share

Integra forecasts Q2 adj. EPS of 40 cents to 45 cents, below estimates of 57 cents - data compiled by LSEG

Co's Q1 results miss Wall Street expectations

Three out of 13 analysts rate stock as "buy" or higher, 6 "hold" and 4 "sell" or lower; Median PT is $22.50 LSG data

Including session's moves, IART stock down 46.4% YTD